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Received 8 September 2014; Accepted 17 January 2015
Academic Editor: Jeffrey M. Weinberg
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Introduction. The major medical concern with giant congenital melanocytic nevi CMN is high risk of developing cutaneous
melanoma, leptomeningeal melanoma, and neurocutaneous melanocytosis. Case Report. A 30-year-old woman with a giant
congenital melanocytic nevus covering nearly the entire right thoracodorsal region and multiple disseminated melanocytic nevi
presented with neurological symptoms. Cerebral magnetic resonance imaging revealed a large expansive lesion in the left frontal
region. Postsurgically pathological diagnosis revealed characteristics of melanoma. Immunohistochemical examination showed
S100(+), HMB45(+),MelanA(+), andMiTF(+). She received radiotherapy with temozolomide followed by twomore chemotherapy
cycles with temozolomide. She followed a rapidly progressive course, reflecting widespread leptomeningeal infiltration, and she
died of multiorgan failure seven months after diagnosis of cerebral melanoma. Discussion. This patient was diagnosed as having
a neurocutaneous melanosis with malignant widespread leptomeningeal infiltration. Diffuse spinal involvement is unusual and is
described in only another patient.
1. Introduction
Congenital melanocytic nevi (CMN) are nevi that are present
at birth or arise within the first few weeks of life [1]. CMN
vary in size from small to very large or giant (GCMN).These
GCMN are commonly associated with benign melanocytic
growths within the substance of the lesion, termed “prolif-
erative nodules.” In addition to proliferative nodules, GCMN
are often associated with “satellite nevi” [2].These are smaller
CMN that are present at birth or arise months to years
later [3]. The major medical concern with giant CMN is
high risk of developing cutaneousmelanoma, leptomeningeal
melanoma, and neurocutaneous melanocytosis.
2. Case Presentation
A 30-year-old woman presented with impaired vision, dizzi-
ness, and headache for one week prior to admission. Physical
examination revealed many brownish-black nevi on the
trunk, including a giant one covering nearly the entire
right thoracodorsal region (32 cm × 20 cm) and another on
the left thigh (25 × 18 cm) (Figure 1). Another cephalic patch
(5 cm × 4 cm) was situated on the frontal region and many
brownish-black nevi on the lower limb some with abundant
hair that appeared during the first years of life.Most nevi were
irregular but showed no clinical signs of malignancy.
The family history was negative for congenital nevi or
melanoma. She was irregularly examined by pediatric. Her
early neurodevelopment had been normal although she had
some learning disabilities.
A computed tomography (CT) scan of the head showed
a hemorrhagic lesion on the medial aspect of the left frontal
lobe, about 4.7 cm inmaximumdiameter.Thatwas associated
with parenchymal edema causing effacement of cortical sulci
and anterior horns of the lateral ventricles. Cerebralmagnetic
resonance imaging (MRI) revealed a large expansive lesion
in the left frontal region associated with hemorrhagic com-
ponent showing rounded morphology and relatively well-
defined contours, but with some papillomatous projections.
This lesion was heterogeneous on T1 with iso- and hyperin-
tense areas, hypointense on FLAIR, and heterogeneous and
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Figure 1: Giant black-brown pigmented nevus, one covering nearly the entire right thoracodorsal region and the other on the left thigh. Note
also satellite nevi on the trunk and extremities.
(a) (b)
Figure 2: Cerebral magnetic resonance imaging revealing a large expansive lesion in the left frontal region. The lesion is heterogeneous on
T1 with iso- and hyperintense areas, hypointense on FLAIR, and heterogeneous and markedly hypointense on T2.
markedly hypointense on T2 (Figure 2). After contrast there
was an intense uptake, inducing important lesion vascularity.
She underwent surgery by bicoronal frontal craniotomy
and despite identification of the lesion (dark, very haemor-
rhagic) the excision was incomplete.
Postsurgically pathological diagnosis showed brain
involvement of neoplastic cells with characteristics of mela-
noma (Figure 3). Histologic examination revealed brain
tissue widely surrounded by thick cell neoplasia, comprising
nests of cells large and bulky presenting irregular nuclei
of coarse chromatin and prominent and eosinophilic
nucleoli. The cytoplasm presented large, dense, and slightly
eosinophilic, occasionally containing melanin pigment. The
neoplastic cells showedmarked cellular pleomorphism. It was
identified numerous mitotic figures. Immunohistochemical
examination exhibited S100(+), HMB45(+), MelanA(+), and
MiTF(+).
In order to find possible origin of the lesion at other sites,
thoracoabdominal-pelvic computed tomography (CT) scan
was done, but no lesions were detected.
She received radiotherapy (the radiation dose was 40Gy
given in 16 fractions of 2.5 Gy each) with temozolomide fol-
lowed by more two chemotherapy cycles with temozolomide
200mg/m2/day (for 5 days).
Six months later she was hospitalized for urinary reten-
tion. Another thoracoabdominal-pelvic computed tomogra-
phy (CT) scan was done, but no lesions could be detected.
Cerebral magnetic resonance imaging (MRI) revealed pres-
ence of uptake in frontal sulci corresponding to infiltration
leptomeningeal tumor.
Spinal cord magnetic resonance imaging (Figure 4)
exposed an extensive metastasis throughout the subarach-
noid space, which extended from D4 with metastatic
clusters hyperintense on T1, hyperintense on STIR, and













Figure 3: Marked cellular pleomorphism and numerous mitotic figures. Immunohistochemical examination showed S100(+), HMB45(+),
MelanA(+), and MiTF(+).
(a) (b)
Figure 4: Reflecting widespread leptomeningeal infiltration, contrast capture was documented in the subarachnoid space from the level of
C2-C3.
iso/hyperintense on T2, capturing intense and homogeneous
contrast. These injuries involved the conus medullaris and
extended along the roots of the cauda equina depositing
itself as nodule formation and metastases were observed at
the inferior end of the dural sac. Reflecting widespread lep-
tomeningeal infiltration, contrast capture was documented in
the subarachnoid space from the level of C2-C3.
The patient was treated with three-dimensional comput-
erized planning dosimetry at a dose of 30Gy in 15 fractions
to the neuraxis. Gradually she had worsening of clinical
symptoms with flaccid paraplegia and sphincter injury with
neurogenic bladder and constipation and she died of multi-
organ failure seven months after diagnosis of melanoma.
3. Discussion
The existing data regarding the risk of neuromelanosis
associated with CMN are imperfect but suggest a convincing
link (range from 2.5% to 45%). Neurocutaneous melanosis
(NCM) is neuromelanosis associated with CMN [4–9].
Neuromelanosis which relates to a congenital error in
the morphogenesis of the embryonic ectoderm describes
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melanocytic proliferation (benign or malignant and nodular
or diffuse) within the leptomeninges and brain parenchyma
[4, 5, 10]. NCM can affect the amygdala, cerebrum, cerebel-
lum, pons, medulla, and spinal cord (20%) [9, 11, 12].
In 1991, Kadonaga and Frieden [13] reviewed the literature
on neurocutaneous melanosis and redefined it as follows:
(1) the presence of large (more than 20 cm) and/or multiple
(more than three) congenital melanocytic nevi (CMN) in
association with meningeal melanosis or melanoma; (2) no
evidence of cutaneousmelanoma, except in patients in whom
the examined areas of themeningeal lesions are histologically
benign; and (3) no evidence of meningeal melanoma, except
in patients in whom the examined areas of the cutaneous
lesions are histologically benign.
Patients with neuromelanosis may be symptomatic or
asymptomatic. There seem to be two peak ages for presenta-
tion of complications fromNCM.Thefirst peak, which repre-
sents themajority of patients, occurs before 3 years of age and
thosewhobecome symptomatic are associatedwith increased
intracranial pressure and include seizures, hydrocephalus,
cranial nerve palsy, hemiparesis, and developmental delays.
The other peak occurs during the second to third decades
of life [6, 13, 14]. Delayed presentation in older children,
adolescents, and adults has also been reported, usually with
symptoms such as headaches or neuropsychiatric manifesta-
tions [15].
Suggested risk factors for NCM have been reported to be
the presence of a GCMN, male sex, satellite nevi or multiple
CMN, and head, neck, or posterior midline location [14–18].
Serial MRI scans may be helpful in monitoring asymp-
tomatic patients who have a positive baseline MRI with
or without signs and symptoms of CNS involvement [19].
The most common finding in this group was the T1-signal
shortening compatible with melanin deposits in the infraten-
torial structures [20]. The FLAIR findings: leptomeningeal
hyperintensity has been also described [21]. However, the
routine MRI examination in these patients is debated as
the sensitivity of MR imaging has permitted detection of
melanosis in about 25% asymptomatic infants [19]. Other
reports of metastatic melanoma also fail to demonstrate the
characteristic signal intensity on MR images [22].
Neurological symptoms were a sign of poor prognosis
and, in this case, the first sign of disease progression. Our
patient developed a very rapid progression of the disease, with
evidence of increasing extent of leptomeningeal enhance-
ment in the brain and cord on the second image. The
first appearance of these masses with vasogenic edema and
hemorrhage was a sign of malignancy, which was confirmed
with the pathological diagnosis. Diffuse spinal involvement is
unusual in this diagnosis, though Rhodes et al. [23] described
this finding in one patient.
Treatment options for symptomatic NCM are unsatisfac-
tory. There is little experience in chemo- and radiotherapy,
with relatively little effects on the symptoms, and no effects
on survival by that care in our patient it were palliative.
Neurocutaneousmelanosis is a rare syndrome.The recent
data suggest that alteration in hepatocyte growth factor
(HGF)/scatter factor (SF) signaling through theMET recep-
tor during embryogenesismight play themost important role
in the development of NCM. HGF/SF signaling through the
MET receptor in melanocytes derived from the neural crest
promotes the proliferation, motility, and melanin synthesis
in vivo [20]. The genetic background of this disorder is not
known; therefore genetic counseling is not applicable.
Imaging neither predicts which patients will become
symptomatic nor identifies those who might benefit from a
proven therapy. Some authors recommend the MRI in the
first 4 months of life, as, due to the poor myelinization of
CNS, the signal of melanin is easier to detect. Close follow-up
with a pediatrician for neurodevelopmental assessment and a
dermatologist for skin examination is the best way to address
high-risk patients.
4. Conclusions
CMN are a diverse group of lesions with significance to
life threatening when associated with MM or NCM. Neu-
rological symptoms in patients with NMC may be also
related to the development of leptomeningealmelanomawith
extremely poor prognosis. A multidisciplinary approach to
these patients is imperative and should consider routine neu-
rodevelopmental assessments along with skin examinations
for these high-risk patients.
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